Global Therapeutic Drug Monitoring (TDM) Service Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Therapeutic drug monitoring (TDM), a clinical laboratory technology that measures drug concentrations to regulate drug dosage, has become an important treatment aid in both inpatient and ambulatory care. TDM laboratory methods, including immunoassay (EIA, FIA, and RIA) and chromatographic techniques, used to assay blood, urine, and saliva samples of patients taking therapeutic drugs; TDM is also useful in identifying abused drugs.
Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects.
According to our (Global Info Research) latest study, the global Therapeutic Drug Monitoring (TDM) Service market size was valued at USD 1856.5 million in 2022 and is forecast to a readjusted size of USD 2324.5 million by 2029 with a CAGR of 3.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global therapeutic drug monitoring key players include Roche, Danaher and Abbott.The top 5 accounts for 60% of the revenue. By region, North America had the highest share of income, reaching 45 percent.In terms of product, blood test is the largest segment, with a share over 70%. And in terms of application, the largest application is hospital labs, followed by independent clinical laboratories.
This report is a detailed and comprehensive analysis for global Therapeutic Drug Monitoring (TDM) Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Therapeutic Drug Monitoring (TDM) Service market size and forecasts, in consumption value ($ Million), 2018-2029
Global Therapeutic Drug Monitoring (TDM) Service market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Therapeutic Drug Monitoring (TDM) Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Therapeutic Drug Monitoring (TDM) Service market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Therapeutic Drug Monitoring (TDM) Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Therapeutic Drug Monitoring (TDM) Service market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Danaher, Abbott, Thermo Fisher Scientific and Siemens Healthineers, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Therapeutic Drug Monitoring (TDM) Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Blood Test
    Urine Test
    Saliva Test
Market segment by Application
    Hospital Labs
    Independent Clinical Laboratories
    Others
Market segment by players, this report covers
    Roche
    Danaher
    Abbott
    Thermo Fisher Scientific
    Siemens Healthineers
    Bio-Rad Laboratories
    bioMerieux
    B�hlmann Laboratories
    Randox Laboratories
    Sekisui Medical
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Therapeutic Drug Monitoring (TDM) Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Therapeutic Drug Monitoring (TDM) Service, with revenue, gross margin and global market share of Therapeutic Drug Monitoring (TDM) Service from 2018 to 2023.
Chapter 3, the Therapeutic Drug Monitoring (TDM) Service competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Therapeutic Drug Monitoring (TDM) Service market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Therapeutic Drug Monitoring (TDM) Service.
Chapter 13, to describe Therapeutic Drug Monitoring (TDM) Service research findings and conclusion.